Cognex Corporation (CGNX) Stake Lessened by Disciplined Growth Investors Inc. MN
Disciplined Growth Investors Inc. MN lessened its stake in Cognex Corporation (NASDAQ:CGNX) by 10.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 802,275 shares of the scientific and technical instruments company’s stock after selling 89,170 shares during the quarter. Disciplined Growth Investors Inc. MN owned approximately 0.93% of Cognex Corporation worth $68,113,000 as of its most recent filing with the SEC.
Several other institutional investors also recently modified their holdings of CGNX. BlackRock Inc. raised its stake in shares of Cognex Corporation by 16,264.7% in the 1st quarter. BlackRock Inc. now owns 6,656,024 shares of the scientific and technical instruments company’s stock valued at $558,773,000 after purchasing an additional 6,615,351 shares in the last quarter. Ameriprise Financial Inc. raised its stake in shares of Cognex Corporation by 126.7% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,342,312 shares of the scientific and technical instruments company’s stock valued at $198,864,000 after purchasing an additional 1,309,047 shares in the last quarter. Coatue Management LLC acquired a new stake in shares of Cognex Corporation in the 2nd quarter valued at about $87,064,000. Goldman Sachs Group Inc. raised its stake in shares of Cognex Corporation by 86.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 888,783 shares of the scientific and technical instruments company’s stock valued at $74,613,000 after purchasing an additional 412,652 shares in the last quarter. Finally, American Century Companies Inc. acquired a new stake in shares of Cognex Corporation in the 2nd quarter valued at about $31,281,000. Institutional investors and hedge funds own 87.25% of the company’s stock.
A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Cognex Corporation from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. Wolfe Research raised shares of Cognex Corporation from a “market perform” rating to an “outperform” rating in a research report on Monday, August 14th. Cowen and Company reaffirmed an “outperform” rating and set a $135.00 price objective (up previously from $100.00) on shares of Cognex Corporation in a research report on Tuesday, August 8th. Finally, BidaskClub raised shares of Cognex Corporation from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 4th. Six investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Cognex Corporation presently has a consensus rating of “Buy” and a consensus price target of $82.75.
TRADEMARK VIOLATION WARNING: This report was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/10/13/cognex-corporation-cgnx-stake-lessened-by-disciplined-growth-investors-inc-mn.html.
Shares of Cognex Corporation (NASDAQ CGNX) traded down 0.0016% during midday trading on Friday, hitting $118.8481. 310,554 shares of the company were exchanged. The stock has a market cap of $10.29 billion, a PE ratio of 54.2933 and a beta of 1.42. The stock’s 50-day moving average is $111.21 and its 200-day moving average is $96.09. Cognex Corporation has a one year low of $49.68 and a one year high of $119.66.
Cognex Corporation (NASDAQ:CGNX) last released its quarterly earnings data on Monday, July 31st. The scientific and technical instruments company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.55 by $0.08. The company had revenue of $172.90 million during the quarter, compared to the consensus estimate of $169.79 million. Cognex Corporation had a net margin of 33.10% and a return on equity of 19.51%. The firm’s revenue for the quarter was up 17.4% compared to the same quarter last year. During the same period last year, the firm earned $0.50 EPS. Equities research analysts anticipate that Cognex Corporation will post $2.55 EPS for the current year.
In related news, Director Bruce Robinson J sold 7,000 shares of Cognex Corporation stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $106.50, for a total transaction of $745,500.00. Following the completion of the transaction, the director now directly owns 5,625 shares of the company’s stock, valued at approximately $599,062.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jerry A. Schneider sold 5,000 shares of Cognex Corporation stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $102.67, for a total transaction of $513,350.00. Following the transaction, the director now directly owns 6,000 shares of the company’s stock, valued at $616,020. The disclosure for this sale can be found here. Insiders have sold a total of 126,750 shares of company stock valued at $13,242,726 over the last ninety days. 5.60% of the stock is owned by insiders.
Cognex Corporation Company Profile
Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX).
Receive News & Stock Ratings for Cognex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Corporation and related stocks with our FREE daily email newsletter.